Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCONEXENT vs DOLUTEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOCONEXENT vs DOLUTEGRAVIR: Safety Overview

Metric DOCONEXENT DOLUTEGRAVIR
Total FAERS Reports 241 10,772
Deaths Reported 3 1,001
Death Rate 1.2% 9.3%
Hospitalizations 215 2,225
Average Patient Age 47.5 yrs 44.5 yrs
% Female Patients 69.8% 42.1%
FDA Approval Date N/A Aug 12, 2013
Manufacturer N/A ViiV Healthcare Company
Route N/A ORAL
Marketing Status N/A Prescription